Latest Capital Raising News

Resolution Minerals Limited has secured the Horse Heaven Project in Idaho, adjacent to the major Stibnite Gold Project, aiming to address critical US antimony supply shortages with a planned 2025 drilling campaign.

North Stawell Minerals has announced a combined $3.6 million capital raise through a placement and a pro-rata entitlement offer, aiming to bolster its exploration activities without materially altering company control.

North Stawell Minerals has launched a $3.6 million equity raising, anchored by a cornerstone investor, to fund exploration at key Victorian gold projects and sustain operational momentum through 2025.

BluGlass Limited has extended the closing date of its Share Purchase Plan to June 13, 2025, giving eligible shareholders more time to subscribe at a discounted price. The move aims to maximize participation ahead of a crucial shareholder vote.

Iceni Gold has raised $2.5 million in an oversubscribed placement to fund key drilling programs at its 14 Mile Well Gold Project and initiate exploration at the Welcome Creek copper-gold target in Western Australia.

QuickFee Limited has launched a Share Purchase Plan offering up to 5 million new shares at a 2% discount, aiming to raise $250,000 to fuel loan book growth and strengthen its balance sheet. Neu Capital Australia Pty Ltd has committed to cover any shortfall, underscoring confidence in QuickFee’s growth trajectory.

Agrimin Limited has locked in a significant 27% shareholding in the upcoming Tali Resources IPO, offering its shareholders a priority allocation worth up to $2 million. The IPO is set to list on the ASX on 21 July 2025, marking a strategic expansion for Agrimin in the lithium and mineral resources sector.

Patrys Limited has raised $358,362 through a share placement and announced significant board changes, including the appointment of Dr Anton Uvarov and Mr Peter Christie, alongside making the CEO role redundant.

Tempest Minerals has completed a pro-rata entitlement offer, raising over $600,000 to fund exploration in Western Australia, though a significant shortfall remains to be allocated.

Chimeric Therapeutics has secured a $2.5 million advance against its FY25 R&D tax incentive, bolstering funding for its clinical trial pipeline and operational needs. This move complements recent capital raises and underscores the company’s strategic financial management amid its oncology-focused cell therapy development.

Alara Resources has announced a private placement to raise A$3.4 million aimed at repaying a significant portion of its Trafigura loan, subject to shareholder approval. The move underscores strong backing from major shareholders and a strategic focus on financial stability.

Aguia Resources has locked in $750,000 through convertible notes to bolster working capital, pending shareholder approval expected in mid-July. The notes carry a 10% interest rate and come with free options, signaling cautious optimism about the company’s near-term funding needs.